Demineralized Bone Matrix (DBM) Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Demineralized Bone Matrix (DBM) Market
The demineralized bone matrix (DBM) market size was valued at USD 1.11 billion in 2023, and the market is now projected to grow from USD 1.18 billion in 2024 to USD 1.94 billion by 2032, exhibiting a CAGR of 6.4% during the forecast period of 2024-2032.
Pandemic disrupted demineralized bone matrix market growth because of lockdown policies, but in 2021, relaxation extended the huge variety of orthopedic strategies and the demand for those merchandise.
The growing wide variety of spinal fusion surgical procedures and dental surgeries is riding the demand for demineralized bone matrix products globally. Herniated discs are greater commonplace in human beings in their third to 5th decade of life, and improvements in surgical strategies are anticipated to growth the variety of spinal fusion surgeries. The demand for DBM solutions is predicted to grow inside the coming years. Additionally, the rise in dental surgeries, which have an effect on almost 3.5 billion humans global, is likewise using demand for DBM merchandise. Dentin caries and gum disorder are the various maximum commonplace sicknesses, inflicting permanent enamel loss, which is driving the call for DBM merchandise in dental implant surgical procedures.
Orthopedic troubles are getting more universal, with 1.71 billion people globally suffering from musculoskeletal conditions. Osteoporosis and fragility fractures purpose over 8.9 million annual fractures, causing a giant burden on society. This provides a growing market for surgical and DBM merchandise, allowing new entrants and mounted players to expand their marketplace presence and launch new products to meet the increasing demand.
Comprehensive Analysis of Demineralized Bone Matrix (DBM) Market
The international marketplace for demineralized bone matrix products is segmented into gel, putty, and others. Putty dominates due to its use in orthopedic and dental disorders, whilst gel is expected to develop at a higher CAGR because of its biocompatible nature and demand for craniomaxillofacial, aesthetic, and trauma surgical procedures. The market is also divided into dental, craniomaxillofacial, spinal fusion, long bone procedures, joint reconstruction, and other applications. Spinal fusion is the dominant segment, driven by the increasing number of spinal cord injuries worldwide. The dental application segment is expected to grow at a significant CAGR due to dental surgeons' preference for DBM products and the increasing number of training sessions for dental practitioners. Hospitals dominate the market due to their high number of bone graft procedures and advanced instruments.
The North America region lead the demineralized bone matrix (DBM) market share by benefitting a market size of USD 0.50 billion in 2023 due to Major businesses like Johnson & Johnson, Zimmer Biomet, and Stryker, in conjunction with rising R&D investments and product launches, contribute to the region's main proportion. Orthofix Medical Inc. Launched Legacy Demineralized Bone Matrix in October 2022, a putty for filling voids in bony defects or disturbing backbone injuries. Technologically advanced merchandise and increased demand from clinical service vendors will boost marketplace boom. Spine Wave, Inc.'s Tempest allograft bone matrix in July 2020 bolstered its position in the DBM market.
In 2023, the fragmented ortho biologics market is dominated by using Medtronic p.C, Johnson and Johnson, Zimmer Biomet, and Stryker. These top gamers are leveraging acquisitions, collaborations, and new product launches to strengthen their worldwide position. Other exceptional players encompass SeaSpine, Xtant Medical, RTI Surgical, HansBioMed, Arthrex GmbH, and Exactech, Inc. These companies are predicted to increase their market proportion thru new product introductions.
In January 2023, Orthofix Medical Inc. And SeaSpine merged to decorate their biologics product portfolio, bone boom treatments, and orthopedic solutions.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 6.4% from 2024-2032
Unit Value (USD billion)
Segmentation By Product Type
Gel
Putty
Others
By Application
Dental
Craniomaxillofacial
Spinal Fusion
Long Bone Procedures
Joint Reconstruction
Other Applications
By End-user
Hospital
Specialty Clinics
Others
By Region
North America (By Product Type, By Application, By End-user, By Country)
- U.S. (By Product Type)
- Canada (By Product Type)
Europe (By Product Type, By Application, By End-user, By Country/Sub-Region)
- Germany (By Product Type)
- U.K. (By Product Type)
- France (By Product Type)
- Italy (By Product Type)
- Spain (By Product Type)
- Scandinavia (By Product Type)
- Rest of Europe (By Product Type)
Asia Pacific (By Product Type, By Application, By End-user, By Country/Sub-Region)
- China (By Product Type)
- India (By Product Type)
- Japan (By Product Type)
- Australia (By Product Type)
- Southeast Asia (By Product Type)
- Rest of Asia Pacific (By Product Type)
Latin America (By Product Type, By Application, By End-user, By Country/Sub-Region)
- Brazil (By Product Type)
- Mexico (By Product Type)
- Rest of Latin America (By Product Type)
Middle East & Africa (By Product Type, By Application, By End-user, By Country/Sub-Region)
- GCC (By Product Type)
- South Africa (By Product Type)
Rest of Middle East & Africa (By Product Type)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.